Patient Recruitment Challenges

Incentive Models for Rare Disease Trial Participation

Posted on digi By digi

Recruiting and retaining participants for rare disease clinical trials is a uniquely complex challenge. The small size and global dispersion of eligible patient populations, coupled with high study burdens, long durations, and frequent travel, make traditional recruitment strategies insufficient. In this context, incentives—both financial and non-financial—can serve as effective tools to boost enrollment and ensure participant retention throughout the study lifecycle.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Addressing Language Barriers in Global Rare Disease Recruitment

Posted on digi By digi

Rare disease clinical trials often span multiple countries and continents in order to reach the small, geographically dispersed patient populations required for statistically meaningful studies. While global recruitment opens access, it also introduces a major challenge—language barriers. Patients and caregivers may be unfamiliar with the primary language used in study materials, informed consent forms, or clinician communication.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Overcoming Travel Burdens for Rare Disease Study Participants

Posted on digi By digi

In rare disease clinical trials, eligible patients often reside far from trial sites, which are typically concentrated in major cities or academic centers. Given the small and globally dispersed patient populations, it’s not uncommon for participants to travel hundreds or even thousands of kilometers to access a site. This travel burden can discourage enrollment, increase dropout risk, and disproportionately exclude rural or low-income participants.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Creating Culturally Relevant Recruitment Materials for Rare Disease Trials

Posted on digi By digi

In rare disease clinical trials, effective recruitment often spans multiple countries, languages, and communities with diverse cultural beliefs, health practices, and literacy levels. Standardized recruitment materials—translated word-for-word—frequently fail to resonate with these populations and can even be misunderstood or distrusted.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Building Trust with Rare Disease Communities

Posted on digi By digi

For rare disease clinical trials, trust is more than a recruitment tool—it’s the foundation of ethical engagement. Many rare disease communities have faced decades of misdiagnosis, neglect, and limited treatment options. When researchers or sponsors enter these spaces to conduct clinical trials, they are often met with justified skepticism and concern.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Recruitment Challenges in Pediatric Rare Disease Trials

Posted on digi By digi

Rare diseases disproportionately affect children—around 50–75% of all rare diseases begin in childhood. Yet recruiting pediatric patients for clinical trials presents unique and often compounding challenges. These include medical, ethical, logistical, and emotional factors that make study participation difficult for families and complex for researchers.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Engaging Patient Advocacy Leaders in Recruitment Strategies

Posted on digi By digi

In rare disease research, traditional recruitment channels often prove ineffective due to the small, dispersed, and diverse patient populations involved. Patient advocacy leaders—who have earned the trust of their communities—are emerging as powerful allies in clinical trial enrollment efforts. Their insights, communication platforms, and grassroots reach make them key players in designing and implementing recruitment strategies that resonate.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials

Targeting Undiagnosed Populations for Rare Disease Studies

Posted on digi By digi

One of the most significant barriers in rare disease clinical research is the “diagnostic odyssey” — the long, uncertain journey many patients endure before receiving a diagnosis. For some, this process takes years, if not decades. Unfortunately, during this delay, many remain invisible to the clinical research community, missing critical windows for therapeutic intervention.
Click to read the full article.

Patient Recruitment Challenges, Rare and Orphan Disease Trials